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The ocean hosts an unprecedented wealth of biodiversity. Deep sea habitats are alone 
estimated to contain between 500,000 and 10 million species, and even though oceans 
constitute about 95 % the biosphere, vast parts are yet to be explored.
1
 Technological 
development is facilitating exploration in more remote and extreme spheres, including areas 
beyond national jurisdiction. Deep sea exploration started in the 1970s, but merely 5 % of the 
saline hydrosphere is thus far scrutinized by oceanographers.
2
 Hence, we especially lack 
sufficient understanding of the biota in extreme domains of perpetual darkness, low 
temperatures and high pressure.
3
 These pristine areas appear to be particularly interesting to 
explore because organisms living under extreme conditions often embody distinctive survival 
systems. Over the last decades there has been an increasing interest in commercial 
opportunities relating to exploration and exploitation of marine biological material. 
 
The Organisation for Economic Cooperation and Development (OECD) nations are 
diversifying their economies and are thus highlighting marine bioprospecting as a prioritized 
area with significant commercial potential.
4
Because the ratio of compounds with practical 
pharmaceutical potential to compounds screened is higher in marine materials, there is a 
greater probability of commercial success compared to terrestrial resources.
5
 During the initial 
phase of bioprospecting, the main goal is to find ingredients, chemical compounds or genes 
that can be applied in products. From an industrial perspective, relevant interests relate to 
medicine, nutrition, cosmetics and process industries, including oil, gas and biofuel. For 
example, marine organisms native to oil wells can potentially be used to explore and produce 
                                               
1
 J. F. Grassle and N. J. Maciolek, ‘Deep-sea species richness: regional and local diversity estimates from quantitative bottom samples’ 
[1992] The American Naturalist 313; Secretariat on the Convention on Biological Diversity, Marine and Coastal biodiversity, available at 
<http://www.cbd.int/undb/media/factsheets/undb-factsheet-marine-en.pdf> accessed 16 May 2013. 
2
 National Oceanic and Atmospheric Administration (NOAA), available at <http://www.noaa.gov/ocean.html> accessed 18 May 2013. 
3
 D.K. Leary, ‘Bioprospecting and the Genetic Resources of Hydrothermal Vents on the High Seas: What is the Existing Legal Position, 
Where Are we Heading and What are our Options?’ [2004] Macquarie Journal of International and Comparative Environmental Law 137. 
4
 OECD, Global Forum on Biotechnology: Marine Biotechnology – Potential and Challenges, available at 
<http://www.oecd.org/sti/biotech/oecdglobalforumonbiotechnologymarinebiotechnologypotentialandchallenges.htm> accessed 15 May 2013. 
5
 Food and Agriculture Organization of the United Nations, Report of the Workshop on Bioprospecting in the High Seas, 2003, available at 
<http://www.fao.org/docrep/008/y5890e/y5890e0d.htm> accessed 24 May 2013; United Nations, Summary of proceedings prepared by the 
Co-Chairs of the Working Group, I/A/10, available at  
<http://www.un.org/depts/los/biodiversityworkinggroup/biodiversityworkinggroup.htm> accessed 22 July 2013. 
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energy more effectively, while organisms in polar rivers can culture valued defense 
mechanisms. Specifically sedentary species which have developed chemical compounds that 
restrain competitors, parasites and predators are among the organisms of interest to 
pharmaceutical bioprospectors.
6
 In the same sector, several promising anti-cancer products 
derived from marine compounds are under development. A report compiled by the US Ocean 
Commission features multiple drugs derived from marine biological material, including ten 
anti-cancer drugs, medicines to combat HIV, dengue, malaria and tuberculosis.
7
 The 
biological diversity in areas beyond national jurisdiction can thus yield a broad variety of 
healthcare innovations. Hence, there is consensus amongst marine scientists and industrialists 
that the genetic resources found in deep sea habitats carry considerable commercial potential. 
There are currently multiple companies involved in research and exploitation of genetic 
resources in e.g. the Arctic, and an analogous amount of patent applications clearly indicates 




However, deep ocean expeditions are still notoriously costly and technically challenging, and 
this may thus far have restrained the ability to exploit and explore the ocean’s common 
resources. The value of a new biotech solution or a company heavily invested in scientific 
endeavors can be difficult to estimate as one has to take into account intangibles such as the 
credibility of its scientists and its patent portfolio.
9
 Further, it takes between seven to nine 
years to launch a new drug to the market and the process usually involves hundreds of millions 
of dollars. Biotechnology entrepreneurs as a consequence often secure their investment by 
using patens, as routine earnings often are absent.
10
 If laboratory trials are successful, non-
routine profits may be vast. Thus, bioprospecting often requires a long-term perspective, 
interdisciplinarity, business expertise, generous capital reserves as well as a corresponding risk 
                                               
6
 D. Farrier and L. Tucker, ‘Access to Marine Bioresources: Hitching the Conservation Cart to the Bioprospecting Horse’ [2001] Ocean 
Development and International Law 213. 
7
 US Commission on Ocean Policy, Connecting the Oceans and Human Health, An Ocean Blueprint for the 21st Century, 2004, available at 
<http://govinfo.library.unt.edu/oceancommission/documents/full_color_rpt/23_chapter23.pdf> accessed 26 June 2013; National Oceanic and 
Atmospheric Administration, Medicines from the sea, 2013, available at 
<http://www.noaa.gov/features/economic_0309/medicines.html> accessed 26 June 2013. 
8
 D. Leary, UNU-IAS Report: Bioprospecting in the Arctic, 2008, available at 
<http://www.ias.unu.edu/sub_page.aspx?catID=111&ddlID=674> 
9
 K. Allen, Entrepreneurship for Scientists and Engineers (Pearson 2010). 
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 Nonetheless, because of the high costs of these cruises, scientists in the public 
sector are also increasingly acquiring external funding and participating in joint ventures with 
industry.
12
 Are these novel concepts and relationships accounted for in the current legislative 
framework? The next section will identify potential legislative gaps. 
 
 
1.2. The Legal Context 
 
The principal source of legislation is in this context the Law of the Sea (LOSC) as it intends to 
regulate “all uses of the oceans and their resources.”
13
 Further, the Convention on Biological 
Diversity (CBD) is a complementing legal source covering the biological material in question, 
in particular sustainable use of natural components and equitable sharing of benefits obtained 
from genetic resources.
14
 The zonal approach in the LOSC has codified state jurisdiction of 
their adjacent continental shelves and economic zones. However, parts of the ocean that are 
located beyond the scope of any nation’s jurisdiction traditionally have fewer restrictions than 
other zones closer to the coastal shore.  
 
In the 1970 UN Declaration of Principles Governing the Seabed and Ocean Floor resources 
are described generally, which could imply that they cover living resources.
15
 The LOSC Part 
XI Art. 133 diverge from this definition by limiting the scope exclusively to minerals; this part 
does as a consequence not cover harvest of genetic resources in, on or under the Area. The 
LOSC does not specify which regime is applicable to marine genetic resources in areas 
beyond national jurisdiction nor do the LOSC and CBD refer to or define the concept of 
bioprospecting. Hence, consistent with the freedom of the high seas, there are no apparent 
restrictions on bioprospecting for marine genetic resources from organisms found on the ocean 
floor. Legislation effectively regulating commercial access to marine biological material is 
                                               
11
 K. Allen, Entrepreneurship for Scientists and Engineers (Pearson 2010); Regjeringen, Marin bioprospektering - en kilde til ny og 
bærekraftig verdiskaping, available at <http://www.regjeringen.no/en/dep/fkd/Documents/reports-and-plans/plans/planer-og-strategier-
2009/marin-bioprospektering--en-kilde-til-ny-.html?id=575822> accessed 13 May 2013. 
12
 S. A. Shane, Academic Entrepreneurship: University Spinoffs And Wealth Creation (Edward Elgar Publishing 2004). 
13
 UN Convention on the Law of the Sea (adopted 10 December 1982, entered into force 16 November 1996) 1833 UNTS 3; UN Convention 
on the Law of the Sea of 10 December 1982, Overview and full text, available at 
<http://www.un.org/depts/los/convention_agreements/convention_overview_convention.htm> accessed 10 May 2013. 
14
 Convention on Biological Diversity 1760 UNTS 79 (adopted on 5 June 1992, entered into force 29 December 1993). 
15
 UNGA Res 2749 (12 December 12 1970). 
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thus absent. The LOSC contains rights and obligations on similar activities; “marine scientific 
research” is for example a comparable concept mentioned as one of the high seas freedoms, 
but there are significant differences between bioprospecting and marine scientific research. In 
the LOSC, marine scientific research requires publication and dissemination of research 
results, while bioprospectors rather on the contrary tend to regularly protect scientific 
solutions through patents to secure their investment. Not only may intellectual property rights 
conflict with the LOSC provisions that prescribe actively promoting and communicating 
research results, they also contribute to inequalities as salient information is unevenly 
distributed among nations. Advanced states host more resourceful institutions and have better 
access to technological equipment required in high seas operations. Of the patents deposited 
on marine genes, there are ten countries who own 90 % of these rights, and 70 % are affiliated 
with the top three, which are USA, Germany and Japan.
16
 As a response to this division in 
capacities to access and benefit from the ocean’s commons, several nations have through the 
United Nations General Assembly (UNGA) Ad Hoc Open-ended Informal Working Group 
(henceforth the Working Group) proposed to develop a more sustainable and equitable 
approach to high seas governance.  
 
The legal gap relating to bioprospecting and genetic resources is problematic because it 
generates uncertainty and diverging practices, which in turn may neglect mechanisms 
supporting innovation and economic development where it is needed the most. The vacuum 
surrounding these biological resources are thus becoming a pressing issue for legislators. As 
marine biodiversity in areas beyond national jurisdiction is a highlighted topic in the 








                                               
16
 S. Arnaud-Haond et al, Marine Biodiversity and Gene Patents, 2011, available at <http://www.imedea.uib-
csic.es/~txetxu/Publications/Arnaud-Haond_2011_Marine.pdf> accessed 11 June 2013. 
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1.3 Sources and Methodology 
The sources of law codified in article 38 of the Statute of the International Court of Justice are 
the rudimentary methodological approach throughout this thesis.
17
 The most sophisticated 
instrument addressing ocean regions beyond national jurisdiction, the LOSC, along with its 
now intrinsic high seas and continental shelf segments, shall constitute the primary convention 
source. To shed light on bioprospectors rights and obligations in connection with innovations 
based on marine biological resources, the WTO Agreement on trade-related aspects of 
Intellectual Property Rights (TRIPS) will provide the legislative material.
18
 The third section 
of Vienna Convention on the Law of the Treaties (VCLT) will be utilized for interpreting the 
essence of the legal provisions.
19
 Furthermore, literature from scholars within relevant 
scientific areas, from natural resources to politics, is used to reflect upon the contemporary 
debate. Judicial decisions are scant in this field and can thus not comprise a significant source 
when canvassing the bioprospecting theme. 
 
In the examination of potential access and benefit-sharing regimes, the above-mentioned 
instruments and institutions are relevant. Nevertheless, since regulation of biotechnology is 
multi-sectoral, involving actors and dimensions from many distinct issue segments, such as 
technological development, food safety, agriculture and environmental protection, the legal 
focus will be largely on the CBD, the Nagoya Protocol on Access to Genetic Resources and 
the Fair and Equitable Sharing of Benefits Arising from their Utilization (Nagoya Protocol) 
and the FAO International Treaty on Plant Genetic Resources for Food and Agriculture (FAO 
Treaty).
20
 In addition, the regulative indications made in the Working Group under the 
auspices of UNGA, the leading deliberative and policy-making unit of the UN, are interesting 
with regard to the current debate. On the other hand, it is important to note that the Working 
Group only holds a suggestive function. Still, this forum up is updated on the matters in 
question, and since these discussions may yield future legislation, the opinions expressed may 
                                               
17
 Statute of the International Court of Justice, United Nations, 26 June 1945, article 38. 
18
 Agreement on Trade-Related Aspects of Intellectual Property Rights (adopted 15 April 1994, entered into force 1 January 1995). 
19
 Vienna Convention on the Law of the Treaties (adopted 23 May 1969, entered into force 27 January 1980) 1155 UNTS 331. 
20
 International Treaty on Plant Genetic Resources for Food and Agriculture (adopted on 3 November 2001, entered into force 29 June 2004) 
2400 UNTS 303; Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their 
Utilization to the Convention on Biological Diversity (adopted 29 October 2010, not yet in force). 
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constitute essential supplements when assessing the contemporary debate. In general, these 
bodies are selected because related issue areas have been addressed therein. 
 
1.4 Exodus Regulative Doldrums? 
By the end of the 69th UNGA session, states have consented to discuss conservation and 
sustainable use of the ocean, which also encompass considering an international instrument 
implemented under the LOSC.
21
 The Working Group is thus far established as the main forum 
to research and discuss matters relevant to areas outside national jurisdiction. This venue is 
interesting because it may comprise a potentially normative function. Henceforth, “marine 
genetic resources, including questions on the sharing of benefits, measures such as area-based 
management tools, including [...] capacity-building and the transfer of marine technology” – 
are set to be debated.
22
 Access to marine biological material and the equitable sharing of their 
benefits is a pivotal yet controversial concept in contemporary international law. The problem 
of translating socioeconomic fairness and sustainable development into substantive 
arrangements has generated a significant governance challenge. The European Union (EU), 
representing a substantial part of the world economy, states that status quo is not acceptable 
and has therefore suggested that the existing FAO Treaty could serve as a reference point for 
an agreement regarding areas outside national jurisdiction. In this approach, balancing access 
and benefit-sharing is regarded as vital. Regarding the outline, a brief structural guide follows. 
In the forthcoming chapter, the legal status of bioprospecting and genetic resources in areas 
beyond national jurisdiction will be investigated. Herein, the potential conflict between 
intellectual property rights and the duty to publicize scientific research will be assessed. In the 
third chapter, feasible access and benefit-sharing mechanism will be analyzed and regulative 
alternatives concerning benefits derived from commercial exploration of marine biota are 
examined. Due course, the question of whether and how regulation should expand, and if so, 
where the supervisory mandate could be placed will be addressed. Finally, the options for 
complementing and strengthening the current framework will be featured.  
 
                                               
21
 UN, Opening dates of forthcoming regular sessions of the General Assembly and of the general debate, available at 
<http://www.un.org/ga/search/view_doc.asp?symbol=A/INF/67/1> accessed 11 June 2013; United Nations General Assembly, Res 66/288 
(27 July 2012) UN Doc A/Res/66/288. 
22
 United Nations, Letter dated 30 June 2011 from the Co-chairs of the Ad  Hoc Open-ended Informal Working Group to the President of the 





Chapter 2 - Contemporary law 
 
 
2.1 Living marine resources 
 
The term “genetic resources” is not located in the LOSC, and has as a consequence been 
debated throughout the decades following its conclusion.
23
 At the time of the LOSC drafting, 
knowledge of marine genetic resources were scarce due to inadequate exploration equipment 
and hence high research and development costs crippled the feasibility of commercial 
activities.
24
 The meaning of biological resources shall thus inter alia be established by 
interpreting its object and purpose, pursuant to article 31 (1) of the 1966 VCLT, which states 
that “a treaty shall be interpreted in good faith in accordance with the ordinary meaning to be 
given to the terms of the treaty in their context and in the light of its object and purpose.” 
Consistent with the Preamble of the LOSC, it is natural to assume that genetic resources are 
included in the provisions covering living resources.
25
 Furthermore, the Conventions capacity 
to adapt to change corresponds with the theory of evolutionary interpretation. 
 
In order to more substantively assert the meaning marine genetic resources, the definitions in 
Article 2 of the CBD may clarify. The LOSC has multiple times been endorsed by the COP of 
the CBD as a legislative framework concerning marine areas beyond national jurisdiction.
26
 
According to the provisions of CBD, biological resources comprises of “genetic resources, 
organisms or parts thereof, populations, or any other biotic component of ecosystems with 
actual or potential use or value for humanity.” Genetic material contains “any material of 
plant, animal, microbial or other origin containing functional units of heredity,” while genetic 
resources equals “genetic material of actual or potential values.” Since there is no universally 
accepted definition of marine genetic resources, this may be the most precise wording in this 
                                               
23
 National Jurisdiction at the 4th Global Conference on Oceans, Coasts, and Islands, April 7-11, 2008. 
24
 L. Glowka, The Deepest of Ironies: Genetic Resources, Marine Scientific Research, and the Area (1996) Ocean Yearbook 154. 
25
 LOSC, Preamble, para. 1. 
26
 CBD, Conference of the Parties (COP), available at <http://www.cbd.int/cop/> accessed 22 June 2013; COP 7, Decision VII/5: Marine and 
coastal biological diversity, 31, available at <http://www.cbd.int/decision/cop/default.shtml?id=7742> accessed 23 June 2013; COP 8, 
Decision VIII/21: Marine and coastal biological diversity: conservation and sustainable use of deep seabed genetic resources beyond the 
limits of national jurisdiction, 6, available at <http://www.cbd.int/decision/cop/default.shtml?id=11035> accessed 23 June 2013; COP 9, 




regard. From this one can confirm that genetic resources are a subsegment of biological 
resources. A broad definition of biological material is adopted in the following sections. The 
definition will thus be pursuant to the above-mentioned CBD description where; marine 
animals, plants, microorganisms and functional units thereof, including heredity of potential or 
actual value, is covered by “marine genetic resources”, “marine biological resources” and 




Bioprospecting is neither applied nor described in the LOSC nor the CBD. There is thus no 
legally binding definition of bioprospecting or international regime governing these activities 
in areas beyond national jurisdiction. As a consequence, the concept appears to encompass a 
broad spectrum of activities.
27
 The International Expert Group convened by the Research 
Council of Norway describes bioprospecting as being “commercial purpose research and 
development, building on use of natural occurring compounds, all the way from first 
discovery, over patenting, benchmarking, improvement, development and 
commercialization.”
28
 In the same manner, the CBD information paper asserts bioprospecting 
as commercially oriented, where bioprospecting is defined as “the process of gathering 
information from the biosphere on the molecular composition of genetic resources for the 
development of new commercial products.”
29
 This understanding does not allow for purely 
scientific studies of genetic resources to be defined as bioprospecting. In this context, “pure” 
research is associated with academia and public research institutions where the main objective 
is to better understand fundamental aspects of nature, while “applied research” is motivated 
rather by solving practical problems and achieving commercial success. However, pure 
research may at later stages evolve into applied research, when compounds capable of solving 
practicalities are discovered. 
 
                                               
27
 S. Arico and C. Salpin, C, UNU-IAS Report: Bioprospecting of Genetic Resources in the Deep Seabed: Scientific, Legal and Policy 
Aspect, 2005, available at <http://www.ias.unu.edu/binaries2/DeepSeabed.pdf> accessed 16 May 2013. 
28
The Research Council of Norway, Possibilities for a bioprospecting commitment in Norway 2008 — 2020: An assessment by an 
International Expert Group. 
29
CBD, Subsidiary Body on Scientific, Technical and Technological Advice, note by the Secretariat on Bioprospecting on the Deep-Seabed, 
24 July 1996, available at <http://www.iisd.ca/biodiv/sbstta/sb215.html> accessed 20 June 2013; COP 5, Decision V/2: Progress Report on 
the Implementation of the Programme of Work on the Biological Diversity of Inland Water, available at 
<http://www.cbd.int/decision/cop/default.shtml?id=7144> accessed 20 June 2013. 
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The UN Secretary General further recognized the commercial aspects of bioprospecting and 
also noted the absence of a universally accepted definition of bioprospecting. He thus in 
parallel stipulated that bioprospecting is “generally understood, among researchers, as the 
search for biological compounds of actual or potential value to various applications, in 
particular commercial applications.”
30
 The last emphasis indicates that both “pure” and 
“applied” research can be considered bioprospecting. As demonstrated, the concept is complex 
and definition of the term is hence disputed, but this thesis will nevertheless apply the broadest 
interpretation of bioprospecting, which includes commercial research which initially may have 
been purely academic. Moreover, a wide definition is applied so as to better reflect the 
problems arising from the lack of substantive content in an emerging concept, which also 
entails the equally challenging absence of adequate legislation that follows. 
 
2.3 Areas Beyond National Jurisdiction 
 
The LOSC applies a zonal approach, where each sphere contains varying degrees of rights and 
obligations. The Grotian concept of freedom of the high seas is echoed in the LOSC Article 
87, and it follows that both coastal and landlocked states may take advantage of these areas of 
open access. Article 87 encloses a non-exhaustive list of freedoms, one of the later additions, 
made after the 1958 Convention, is the capacity to conduct scientific research.
31
 
Bioprospecting is not among the freedoms explicitly listed in Article 87 (1). While some argue 
that this is because it’s a part of the freedom to conduct scientific research, others claim that 
it’s rather because the list of enumerated freedoms are incomplete, which is indicated by the 
preliminary use of “inter alia”. Marine usages that were not anticipated at the time of the 
LOSC drafting can accordingly be covered by this provision. Because biological resources are 
not a part of the Convention’s Part XI Area regime, genetic resources both in the water 
column beyond the EEZ boundary and the ocean floor beyond the limits of the continental 
shelf, are subject to high seas freedoms.
32
 These freedoms are to be exercised with due regard 
to other states’ interest in the LOSC Area, and in conformity with other corresponding parts of 
                                               
30
 United Nations, A/62/66, para. 150, 12 March 2007. 
31
 D. R. Rothwell and T. Stephens, The international Law of the Sea (Hart Publishing 2010) 155. 
32
 A. Proelss, ABS in Relation to Marine Genetic Resources, in E.C. Kamau & G. Winter (eds.), Genetic Resources, Traditional Knowledge 





 This freedom is thus not absolute. States may restrict the extent of 
the high seas bioprospecting activities by regulating watercrafts flying their flag, as well as the 
nation’s corporations and individuals. However, the states capacity to regulate activities and 
resources on the high seas are equally limited by corresponding LOSC provisions. For 
example, states must make sure that national bioprospectors doesn’t interfere with scientific 
research or licit mining operations conducted in the Area. Further, it’s not possible to 
disregard the general duties to preserve and protect the environment.
34
 The LOSC Articles 116 
to 120, addressing management and conservation of living resources, contains obligations as 
well. These environmental measures are backed by CBD Article 7 (c) demanding 
identification and supervision of activities and processes that can damage biodiversity. 





Figure 1. Areas beyond national jurisdiction in blue. 
 
 
                                               
33
 LOSC, art. 87 (3). 
34
 ibid, art 192, 194 to 196; 204. 
35
 ibid, art 88 and 141. 
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2.4 The Legal Status of Bioprospecting in the Commons 
 
It is clear that the current international system is insufficiently crafted with regard to 
bioprospecting. This section will feature an analysis focusing on bioprospecting as an activity, 
to further shed light on how it is regulated under the LOSC and related instruments. It will 
detect legal grounds that may cover bioprospecting and examine different conditions that 
follow from the exsisting legal backdrop. The second section will be resource-oriented, which 
will enable identifying the legality of bioprospecting natural resources.  
 
The LOSC Part VII announces that the highs seas are equally open to all. If bioprospecting is 
subject to this part, then biological resources are open for all and bound by the obligations that 
ensue. A central question is thus how the freedoms of the high seas relate to bioprospecting. 
Article 87 lists activities that are subject to such a freedom: navigation, fishing and scientific 
research. But the non-exhaustive nature of this catalog leaves room for different 
interpretations, and a closer look at the relationships between the listed activities and 
bioprospecting is further needed to resolve essential features of its legal status. 
 
2.4.1 A High Seas Activity 
 
The flag state has exclusive jurisdiction on the high seas, and the connection between the 
vessel and the state shall accordingly be qualified by a genuine link.
36
 Sampling biological 
material involves supplementary activities and generating earnings from more than mere 
transportation. The diverging objectives of the activities indicate that navigation provides 
inadequate coverage for bioprospecting. One also has to take into account the different levels 
of stringency in the distinctive zones of the LOSC. Related activities carried out in the EEZ 
and on the continental shelf, such as marine scientific research, are subject to the consent of 
the coastal state, while exploring and exploiting resources is dependent on the coastal state’s 
sovereign rights.
37
 Further, conducting scientific research in the territorial waters of another 
state may be deemed non-innocent and can thus be regulated by the coastal state.
38
 Yet, this 
doesn’t mean that high seas navigation necessarily is exposed to the same rights and duties as 
                                               
36
 LOSC, art 92; 91. 
37
 ibid, art 246; 56. 
38
 ibid, art 21. 
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other zones, but there are neither indication suggesting a broader interpretation for the high 
seas compared to the EEZ. Hence, the natural interpretation of navigation and bioprospecting, 
implies that bioprospecting is not a high seas freedom on the grounds of being associated with 
navigation. Likewise, navigation is a necessity and a prerequisite for bioprospectors on the 
high seas, and will thus be an integral part of the cruise. Bioprospectors therefore cannot 
ignore the basic provisions on navigation, but neither does it provide satisfactory coverage.  
 
Fishing is another bordering high seas freedom enlisted in the LOSC Article 87. Can 
bioprospecting be considered to be “fishing” and thus be open to all states? The LOSC doesn’t 
define fishing, and fishing for commercial utilization will serve as a suitable reference in this 
regard. Like fishing, collecting living resources from the sea is an inherent part of 
bioprospecting, also, they exploit living resources for predominantly commercial purposes. 
Yet, these activities are not identical. Some legal instruments contain broad definitions of fish; 
e.g. non-sedentary molluscs and crustaceans found in the 1995 Fish Stocks Agreement, still 
bioprospectors amass a greater diversity of species compared to a merchant fishing vessels.
39
 
Further, it’s not customary to use “fishing” nor “harvesting” when sampling marine biological 
material, also high seas fishing intend to maximize yield by harvesting large quantities of the 
resource, while bioprospecting in contrast doesn’t profit from the volume, but instead detect 
material with commercial potential. Products derived from fish have a concentrated market, 
where it’s predominantly valued as a source of food. Genes gathered during bioprospecting 
activities are in comparison exposed to a fragmented market targeting diverging segments, and 
is therefore not only applicable to the food industry, but largely also in the health, alternative 
energy and cosmetic sectors. Altogether, use, objectives and collecting methods can differ 
substantially, and as a consequence the substantive content of the terms “fishing” and 
“bioprospecting” are not very compatible. 
 
2.4.2 Marine Scientific Research 
 
A number of compelling regime changes evolved during the LOSC law-making negotiations 
on marine scientific research. Both customs and convention were altered in the process. 
                                               
39
 United Nations Conference on Straddling Fish Stocks and Highly Migratory Fish Stocks (adopted on 4 December 1995, entered into force 
11 December 2001) 2167 UNTS 88, art 1 (c) 
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Coastal state jurisdiction over marine scientific research expanded; the territorial sea was 
broadened, the 200 nm continental shelf and the new, equally broad exclusive economic zone 
(EEZ) manifested itself.
40
 The jurisdictional scope was also extended in terms of ability to 
withhold consent to conduct marine scientific research in the EEZ and on the continental 
shelf.
41
 Part VI covering the continental shelf, restrains the conduct of marine scientific 
research on the seabed, since this territorial segment is subject to coastal state’s sovereign 
rights. “Scientific research” is not defined in LOSC, which is also the case for the extended 
term, “marine scientific research”, and LOSC does not clearly resolve whether these concepts 
are to be interpreted separately or as a consolidated unit.
42
 Article 87 explains that the freedom 
of scientific research is to be read in conformity with Parts VI and XIII, the latter specifically 
devoted to marine scientific research, which indicates interchangeability. Part XIII are to be 
applied when the scientific research is considered “marine”, e.g. largely when research is 
directly involved with the saline hydrosphere. Data collected at sea intending to study non-
maritime spheres, such as astronomical or atmospheric surveys, does not qualify as marine 
scientific research, and is thus not a part of the LOSC regime.
43
 Scientific research conducted 
outside the subsoil, ocean floor, water column or surface of the marine environment is neither 
subject to LOSC.
44
  Bioprospecting is in this context specifically involved in the marine realm 
when sampling genetic resources. In this regard, it’s not unnatural for bioprospecting to relate 
to marine scientific research, but in order to find the regime compatibility; a comparison of the 
concepts will be sought. Marine scientific research covers academic research in inter alia 
biology, biotechnology, chemistry, and oceanography. The objectives may deviate, still, 
research data is essential in a prudent resource analysis, whether commercially oriented or 
purely scientific.
45
 Transfer of technology from these activities, benefits the international 
community, and accordingly communicating scientific results and making them available to 
the public is an important element in this process. 
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To clarify the activities in question, it’s appropriate to further ascertain whether 
bioprospecting can be stowed under the marine scientific research umbrella. To explain these 
concepts, one must once again direct attention to the history of the LOSC. Even though marine 
scientific research was not addressed explicitly in the list of freedoms of the 1958 Convention 
of the High Seas, the Commission had acknowledged it as a freedom with roots in customary 
law.
46
 A distinction between “pure” and “applied” science was introduced in the 1958 
Convention on the Continental Shelf, which regulated the coastal state’s sovereign rights and 
the rights of third parties to perform marine scientific research on the continental shelf.
47
 
Generally, a coastal state should not withhold consent for research with “a view to pure 
scientific research into the physical or biological characteristics of the continental shelf.”
48
 
During the LOSC consultations, the debate about the distinction between pure and applied 
sciences reemerged, and disagreement about the necessity to detail the distinction between 
these two types of research, is referred to as one of the reasons why a definition is absent.
49
 
The ones objecting to more specific provisions argued that Part XIII provided sufficient 
coverage.
50
 Although, the ongoing debate about the meaning of marine scientific research, 
may counter the notion of an adequate description being enclosed in the legislation. Yet, 
benefits can also be associated with the absent definition, because it may be easier to evolve 
with future scientific developments. The understanding of marine scientific research has thus 
developed along with expanding jurisdictions and the emergence of new concepts, such as the 
regions outside national jurisdiction and its related common heritage.  
 
The phrasing of the LOSC Article 87 and Part XIII indicates that research related to 
commercial operations in the high sea areas can be classified as marine scientific research. 
Marine scientific research in areas beyond national jurisdiction was not explicitly included as 
commercially oriented research; neither did the states permit exclusion. Yet, the fact that the 
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proposed division between “applied” and “pure” research was actively rejected should be 
highlighted at this stage. This indicates that there are strong interests that oppose a distinction. 
Because of the absence of a codified distinction between pure and applied sciences on the high 
seas, it is the ordinary meaning without any clear distinction that prevails. 
 
Although the LOSC does not separate pure and applied research in areas beyond national 
jurisdiction, there are in practice a distinction applied in the EEZ and on the continental shelf. 
Coastal states have the right to withhold consent to marine scientific research operations 
proposed by other states and organizations in their EEZ or continental shelf, when the 
operations initiated are of explicit “significance for the exploration and exploitation of natural 
resources”.
51
 However, when marine scientific research projects intend to expand mankind’s 
scientific knowledge of the marine sphere, proposals shall normally be granted.
52
 The former 
objective accordingly relates to commercial projects, while the latter represents pure scientific 
operations.  
 
The Area similarly differs between “exploration and exploitation” or “prospecting” 
administered by the International Seabed Authority, and marine scientific research which, in 
conformity with Article 256, any state or international organization can more freely engage in 
for the benefit of mankind.
53
 Because this discrepancy is applied in the Area in addition to the 
EEZ and the Continental Shelf, commercial research might not either effectively overlap with 
marine scientific research in the high seas.  
 
To separate marine scientific research from commercial research, one has to detail the limits 
of these concepts further. A criterion has to be formulated in order to identify when a project is 
deemed fundamentally scientific or rather research catering to a broader array of uses. The UN 
Secretary General noted that “the difference between scientific research and bioprospecting 
therefore seems to lie in the use of knowledge and results of such activities, rather than the 
practical nature of the activities themselves.”
54
 The end of a marine expedition cruise can thus 
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provide a restriction for when to measure the differences. To base the separation on something 
from an earlier stage in the research process, such as intent of the researchers, may prove 
futile. There may be multiple objectives in one research project, and thus a unified intent may 
be difficult to establish. Further, one also has to assume that this intention will not change, 
which is problematic because academic scientists might at a later stage discover novel 
applications for their compounds. 
 
There is a need to question the conditions applicable to research at sea, when addressing the 
claim of bioprospecting being a subsegment to marine scientific research. In Article 240, the 
LOSC provides the general perspectives applicable to marine scientific research. It must be 
“conducted exclusively for peaceful purposes” and shall be “conducted with appropriate 
scientific methods” while not unjustifiably interfering “with other legitimate uses of the sea.”
55
 
This principle addresses the equal access of all states to areas beyond national jurisdiction. 
Marine scientific research shall further be conducted in “compliance with all relevant 
regulations adopted in conformity with this Convention including those for the protection and 
preservation of the marine environment.”
56
 These are thus the general frames established in 
the LOSC, but a larger complex of substantive rights and duties, and the connection between 
these and bioprospecting is examined in subsequent chapters. 
 
General principles of marine scientific research are stipulated in the LOSC Articles 242 to 
244, which contains a duty to communicate and distribute knowledge and information 
obtained from research in the hydrosphere. Cooperation is further required to enhance the 
scientific understanding of the ocean, for example by transferring data and results from 
research activities particularly to developing countries lacking capacities to conduct these 
operations themselves. A further investigation of these duties are necessary to shed light on 
obligations associated with bioprospecting, which again may clarify if it is appropriate to 
define bioprospecting as a subsegment of marine scientific research. This can potentially 
underpin the analysis on high seas access and benefit-sharing in subsequent sections, 
especially since the duty of sharing knowledge can constitute an integral part of this concept. 
 
                                               
55





Firstly, it is necessary to resolve more precisely what the LOSC prescribes to be scientifically 
publicized and shared as well as how this process shall be conducted. Article 244 requires that 
states and qualified international organizations must secure availability “by publication and 
dissemination through appropriate channels information on proposed major programs, their 
objectives as well as knowledge resulting from marine scientific research.” States are obliged 
to independently and in concert with others to proactively encourage the flow of scientific 
knowledge, as long as it doesn’t put a state’s pivotal security interests at risk.
57
 What is to be 





Biotechnology is the most common industry for academic entrepreneurship. More than half of 
the spinoffs initiated at Massachusetts Institute of Technology from 1980 to 1996 were 
biotechnological and software firms, while over two thirds of new ventures in the University 
of California system were more specifically in health-related industries; i.e. pharmaceutical, 
biotechnology or medical device companies.
59
 Most biotechnology is licensed from 
universities and research institutions and not owned by a company.
60
 The leading research 
universities in United Kingdom, Canada and USA have established technology transfer offices 
with experts who register staff and faculty innovations and licenses the most attractive 
inventions out to private companies that commercialize them.
61
 Bioprospecting is usually 
regulated by contracts negotiated by the institution and its financial supporters. These 
entrepreneurial networks of public-private interactions blur the lines between pure and applied 
research. An extensive amount of empirical evidence suggests that universities are less willing 
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Academic patent regimes may restrict the ability to disseminate scientific knowledge, and 
additional agreements with industry may effectively bar publication. A survey conducted on 
academics in the field of biological sciences found that entrepreneurial scientists, ie start-up 
shareholders, were considerably more inclined to withhold scientific results from colleagues 
compared to other academic researchers.
63
 Academic start-ups can thus reduce the amount of 
scientific knowledge shared with public. Yet the picture is not entirely black and white, 
Google executive Eric Schmidt, through his Schmidt Ocean Institute, for example funded a 
$94 million research vessel set to study the deep ocean.
64
 Scientists can use these facilities free 
of charge as long as they communicate their research findings and make their scientific data 
publicly available.
65
 In that way, the outcome of complex private-public relations may be 
compatible with both the LOSC provisions and the interests of the international community. 
 
Effective communication of scientific research can also be hampered because patent offices 
often require that inventors file for a patent prior to publishing their results and publication is 
usually set to 18 months after the earliest date of priority. However, publishing after the patent 
is awarded does not directly conflict with the LOSC, Article 244 does for example not provide 
a time frame for publication, given that it is not bound by other impeding arrangements. 
Furthermore, while exclusive licensing provides economic incentives to commercialize an 
innovation, the protection may also prevent an entrepreneur that can bring the technology to 




The LOSC Article 244 stipulates the obligation to facilitate information availability by 
dissemination and publication of marine scientific research. This duty is directed at qualified 
international organizations and states, but their nationals are not referred to. As a consequence, 
merely research results where states are stakeholders are explicitly required to release 
scientific results to the public domain. If national laws does not fill in the gap for private 
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actors, one could risk that only a portion marine research results could be under the obligation 
to be made public. Yet, such an outcome appears to conflict with the overall intention of the 
Article 244, as this section also serves as a mechanism stimulating proactive knowledge 
sharing regardless of the patron being the state or its nationals. A customary understanding of 
the duty to make marine scientific knowledge accessible indicates that active publication 
attempts are necessary; reacting to other states inquiries would alone hence be insufficient. 
Further, it is reasonable to interpret appropriate channels for publication as a combination of 
several credible academic forums, whether conferences, workshops, digital and printed 
journals, official web pages of scientific institutions as well as its associated social media 
channels. A patent invention disclosure may also be added to the appropriate channels of 
publication, as it may contain information of practical value to the international community. 
TRIPS Article 29 (1) prescribes these disclosures must be adequately “clear and complete for 
the invention to be carried out by a person skilled in the art,” a phrase which is also found in 
Article 83 of the 1973 European Patent Convention.
67
 A disclosure of invention is rich in 
technical detail, and forms, along with the claims, the scope of the requested protection. At 
least one of the claims must contain utility, novelty or non-obviousness. Accordingly, the 
patent lawyer will word the claims in a way that is sufficiently broad so as to cover all the 
possible technology applications, yet similarly also specific enough to display uniqueness.
68
 
There are no detailed guidelines in the LOSC regarding the composition and exhibition of the 
scientific information, so when it comes to patents, disclosure information is more easily 
accessible to those practicing within the same technological discipline. Information is not 
normally included it comes to the geographical origin of natural resources, except for when it 
is regulated at the national level. Disclosure of origin has gained currency with the 
introduction of the CBD, it assigns measures to facilitate biodiversity conservation and 
research, and in relation to these activities it recognizes the country of origin as an important 
steward.
69
 Requiring disclosure of origin would be a compelling action in support of CBD 
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Article 16 (5), which stipulates cooperation among parties to certify that intellectual property 




In 2006 Norway proposed an amendment of the TRIPS Agreement conforming to the 
objectives of CBD, which includes a more equitable distribution of the benefits arising from 
genetic resources.
71
 Norway is the first OECD country to submit a revision of the TRIPS on 
this matter, and is thus a proponent of legislation requiring patent applicants to disclose details 
about the genetic resources utilized in the invention.
72
 The proposal entails that biological 
information must be included in the patent filing before it can be processed; the patent filer 
shall also enclose if the country of origin requires a permission to access the country's genetic 
resources.
73
 Thus far, the proposal has not gained sufficient support for amending TRIPS, and 
patent filers are hence free to omit details on biological material collected in areas beyond 
national jurisdiction. However, this exclusion may not be significant since Article 244 shall be 
enforced in all areas and does not prescribe inclusion of the marine zone in which the research 
was conducted. It is further not clear if it follows from Article 244 that one should specify in a 
publication that the information is acquired from marine research. As long as the research is 
distributed, there is no explicit duty to enclose the role of marine scientific research. When 
read in light of the general ambition of promoting and facilitating the conduct of marine 
scientific research, perhaps it ought to be included when possible as it would bring attention to 
the segment.
74
 What such a requirement may yield is however questionable. 
 
Accurately describing an invention based on a microorganism with the intention of a third 
party to replicate the process can be difficult, if not impossible. As a replacement or 
supplement for a written declaration, multiple states have settled for the deposit of 
microorganisms as sufficient disclosure in marine bioprospecting. A disclosure of a more tacit 
nature may thus be accepted. The Budapest Treaty on International Recognition of the Deposit 
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 LOSC, art 239; 243; 255.  
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of Microorganisms for the Purposes of Patent Procedure (The Budapest Treaty) covers these 
deposits. The treaty supported by 78 parties, confirms that the biological material only needs 
to be deposited at one internationally acknowledged authority, and this deposit will 
consequently be recognised in all member countries.
75
 Third party depository access is not 
codified in the treaty, and a question of availability is thus subject to the discretion of the 
patent holder. Nonetheless, the Budapest Treaty does limit public access in Article 9 by 
requiring rigid secrecy concerning the deposit and its nature. The Budapest Treaty may thus 
counter national efforts to enforce the LOSC provisions relevant to marine scientific research, 
as this regime does not actively mediate publication and distribution of scientific results. 
Research on marine genetic resources may be impeded by a nexus of patents and contractual 
arrangements, and therefore the LOSC Article 244 may not be complied with under certain 
circumstances. 
 
Bioprospecting can perhaps be subject to the same high seas freedom as marine scientific 
research, yet patents and its related obligations counter the duties found in the LOSC on 
promotion, publication and distribution of marine scientific research. Current benefit sharing 
instruments are thus not utilized effectively, and an implementation gap follows as a 
consequence. Important LOSC duties covering marine scientific research are not compatible 
with the provisions protecting intellectual property rights. The implementation gap in 
combination with conflicting regimes, as well as bioprospecting having an objective of profit 
does convincingly counter the notion of bioprospecting as a subsegment of marine scientific 
research. Other legislative opportunities must thus be examined further to develop a more 
customized regime. The basics of inventions and intellectual property rights concerning 
biological material has been established at this point, and it is now appropriate to proceed with 
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2.4.3 An Unprecedented Concept? 
Since none of the apparent high seas freedoms sufficiently covers bioprospecting, and the list 
of high seas freedoms provided in the LOSC Article 87 is not exhaustive, there may be room 
for an unique solution. Should that be the case, identifying the relevant requirements of this 
freedom is necessary. Bioprospecting shares traits with freedoms included in Article 87. Thus, 
these similarities may advocate that bioprospecting shall be encompassed by this provision. 
Collecting living resources from the ocean is equally open to all, yet restricted by the 
environmental clauses in Part VII, while marine scientific research can be conducted with 
varying degrees of freedom, depending on the intent. Normally, marine scientific research 
should be granted. The intention of bioprospecting may differ from pure scientific research, 
but the scientific procedures are interchangeable. A commercial orientation is not alone 
enough to strictly limit this freedom, as industrial fishing is permitted in these areas. There are 
no rules altogether excluding bioprospecting from the high seas freedoms, and although 
bioprospecting has been practiced for decades on the high seas, there have been no recorded 
proposals against allowing these activities. Custom are thus a strong indicator of its standing. 
Due to the lack of objections, the argument pro considering bioprospecting as covered by the high seas 
freedom is compelling. Accordingly, there is not much doubt about this being an accepted practice. 




2.5 The Legal Status of Genetic Resources in the Commons 
 
In the next chapters, the resource dimension of bioprospecting will be utilized to better 
understand the rights and duties relevant to these activities. This means scrutinizing the 
legislation that affects marine genetic material used in commercial exploration and 
exploitation. Further, clauses covering these high seas resources will be examined, before 
analyzing the legality of bioprospecting in adjacent zones. The genetic resources of the areas 
beyond national jurisdiction is perceived as shared resources open to all, yet biological 
material in the high seas is not addressed explicitly in the LOSC. The freedom to exploit high 
seas resources are subject to limitations which are intended to secure sustainable use of the 
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common resources. Thus, the provisions regulating high seas exploitation of marine living 
resources holds restrictions of relevance. 
 
2.5.1 The Continental Shelf 
 
During the early part of the 20th century, cost-effective exploitation of the resources on the 
continental shelf was facilitated by enhanced marine technology. In the absence of a 
legislative instrument regulating access to these resources, unilateral claims were made to the 
seafloor. The most notable of these was the U.S. President Truman’s claim of exclusive rights 
to seabed resources, which provoked similar proprietary declarations by other states.
76
 These 
claims were further cemented through customary law, the negotiation of bilateral treaties, the 
Convention on the Continental Shelf, by ICJ decisions, and last, but not the least, the LOSC.
77
 
The LOSC concluded an even more extensive codification of the continental shelf by 
designating a 200 nm continental shelf to coastal states, irrespective of seabed composition, as 
well as a possibility to claim an extension where the shelf continued to a continental margin 
beyond 200 nm.
78
 These rights are not dependent on proclamation or occupation; hence, the 
coastal states are naturally bestowed with sovereign rights for the purpose of exploring and 
exploiting natural resources in the physical continental margin.
79
 Because coastal states can 
determine whether to explore or exploit their resources as well as whether or not to allow other 
states access to their resources, these rights are considered exclusive.
80
 The early continental 
shelf provisions covered exclusively mineral resources, but this was subsequently extended to 
include sessile fisheries; those persistently connected to the ocean floor.
81
 The LOSC 
addresses resources on the highs seas regardless of where in the water column it is located, but 
the situation of the resources on the seabed is rather more complex. This section will hence 
deal with questions that concern which legal regime these resources are affiliated with. 
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Exploring and exploiting continental shelf resources oblige an explicit consent from the 
coastal state.
82
 Nonetheless, the legal status of the waters superjacent to the seabed is not 
affected by the continental shelf rights of the coastal state.
83
 The text gets more intricate when 
interpreted in relation to the codification of natural resources, which are “mineral and other 
non-living resources of the seabed and subsoil together with living organisms belonging to 
sedentary species.”
84
 This provision very accurately mirror the wording of the preceding 
Convention on the Continental Shelf, and in concert they both define sedentary species as 
“organisms which, at the harvestable stage, either are immobile on or under the seabed or are 
unable to move except in constant physical contact with the seabed or the subsoil.”
85
 This 
indicates that the deep seabed biological resources located within the 200 nm coastal state 
jurisdiction and are considered sedentary, are included in the continental shelf regime in 
conformity with Article 77 (1) and (4). However, resources that are non-sedentary are 
regulated by the EEZ regime, while the high seas regime covers biological resources from 
non-sedentary species situated above or on the continental shelf beyond the 200 nm limit. Not 
all these species does therefore need consent from the coastal state to be exploited. The LOSC 
does not elaborate on the “harvestable state” qualifier, but it is logical to interpret it as being in 
a somewhat mature phase of its life cycle. On the contrary, the “harvestable state” can be more 
difficult to define in connection with bioprospecting, as the matureness of an algae or fungi is 
not as easily diagnosed. Theoretically constructed provisions may not be compatible with the 
nature of deep sea ecosystems, and a degree of artificiality persists in the division between 
free-swimming and sedentary species.
86
 The act of removing sedentary fisheries from the high 
seas freedom and including it in the continental shelf regime, also sparked controversy, as 
some sessile species naturally are a part of the continental shelf, e.g. mussels and corals, while 
other species that are also considered sedentary are only present on or in the continental shelf 
for part of the life cycle, e.g. oysters, crabs and lobsters.
87
 This demonstrates the challenge of 
applying law to activities that were not properly addressed by legislators during the drafting 
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process. An investigation of the legislation governing bioprospecting in the water column of 
the Area, will be the focus of the upcoming section. 
 
2.5.2 Abyssal resources 
 
The the development of deep seabed resource regulation is one of the most significant and 
belligerent processes of the LOSC law-making history. The LOSC Article 1 (1) defines the 
Area as “the seabed and ocean floor and subsoil thereof beyond the limits of national 
jurisdiction”. The LOSC does not define “seabed”, “ocean floor” and “subsoil”. It is hence 
essential for legislators to further define the term “seabed” in order to better distinguish the 
Area from the superjacent water column. For example, whether the seabed exclusively implies 
seabed materials of solid substance or whether it also can contain gases and liquid compounds 
is a question of relevance. Another issue prompted in this context is whether the mineral rich 
waters of hydrothermal vents belong to the Area or its neighboring water column. There is 
thus a need for examination of regulation addressing biological resources in the intersection 
between the high seas and the Area. 
 
The LOSC acknowledges that there are differences between the water column and the seabed. 
For instance, the LOSC Article 135 acknowledges that the overlaying waters of the Area 
should not be legally affected by the regulative regime of Part XI. Marine scientific research is 
separately addressed in Area and the water column above the EEZ, still, Articles 256 and 257 
do not define the substantive content, but merely implies that distinct standards are to be 
applied.
88
 Factors that may determine the regulative regime the resource is subject to, includes 
whether the material readily can be separated from the encompassing water, as well as its 
relative position to the seabed.
89
 The LOSC Article 133 affirms that the Area’s uppermost 
boundary ought not to be founded on a narrow perception of the “seabed,” as all solid, gaseous 
or liquid minerals “in the Area at or beneath the seabed” implies that the Area cannot be 
restricted solely to the seabed, but rather also can include areas beyond the seabed as well.
90
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Burke supported this notion by suggesting that the LOSC Part XI also covers the mineral rich 




The specific legislation covering the Area is located in the LOSC Part XI, and because Article 
133 (a) defines “resources” as mineral resources, biological material are thus not considered 
“resources” in the Area. One of the main principles governing the Area and its resources is 
“the common heritage of mankind”, found in Article 136. Other core elements in this doctrine 
include inter alia reservation from appropriation of the seabed by states or private entities, 
benefit sharing and international governance through the International Seabed Authority 
(ISA). Since Part XI excludes biological resources, ISA is confined to control and coordinate 
mineral resources. Yet, extensive commercial mining is not considered economically viable 
after the 2008 financial crisis, and interest is therefore currently limited. On the contrary, 
bioprospecting is more widespread in the deep sea, although genetic resources are not 
regulated explicitly in these environments. 
 
There is thus a need for investigation of which regulative regime is appropriate for the living 
resources of the deep seabed beyond national jurisdiction. Common benefits would be 
promoted by open access and scientific publication, if the regime of high seas marine 
scientific research were to apply. But this approach may be impeded by the legal division 
between mineral prospecting and marine scientific research. The 1994 Agreement Relating to 
the Implementation of Part XI did not address genetic resources, even though bioprospecting 
operations were viable at the time.
92
 The contemporary status of genetic resources is thus a 
result of certain states opposing regulation on these resources. The prevailing outcome is 
therefore that these resources remain a segment of the high seas, as the “common heritage of 
mankind” concept is difficult to enforce on these resources in the Area. It is presently perhaps 
more reasonable for legislators to first resolve the separation of continental shelf resources 
from the high seas before taking on the onerous resource distinction in the Area and the deep 
seabed. 
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2.5.3 Intellectual Property Rights 
 
If bioprospecting is a part of marine scientific research, one ought to establish which 
conditions apply to bioprospecting. Consequences considered onwards may inherently 
comprise of arguments pro and contra perceiving bioprospecting as a marine scientific 
research segment. Although, the LOSC is not in general perceived as an instrument of 
intellectual property rights, exclusive rights are regularly sought under the jurisdiction of one 
or more states, to protect inventions derived from bioprospecting. Further, a short outline of 
the most important aspects of intellectual property law and an examination of whether and, if 
so, how the LOSC impacts bioprospectors who pursue such rights, will follow to add further 
clarity to the relationship between public and private law. Multiple economic theories asserts 
that intellectual property rights benefits the international community by equipping 





Intellectual property rights are a temporary monopoly on a specific technology, and it is 
subject to the national and regional legal structures where protection is awarded. The area 
where protection is acknowledged, also defines the jurisdictional scope of the patent, and the 
patent owner can thus prohibit making, selling and importing of products illicitly based on the 
patented solution. The patent is thus considered the most powerful intellectual property 
protection. Global minimum standards for national regulation are established by the WTO 
TRIPS, and through this agreement members are obliged to make patents available for 
products and processes which are novel, contain an inventive step and have the capacity to be 
applied on an industrial scale.”
94
 Likewise, member states may protect health and nutrition; 
stimulate public interest of significance to technological and socioeconomic development.
95
 
One of the problems associated with this agreement, is that is does not prescribe regulation 
explicitly for innovations based on resources from areas outside national jurisdiction. Further, 
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the origin of the genetic resources, which may facilitate the state of origin to exert control and 
claim benefit-sharing is not required in patent law. The EU is among the proponents of 
amending the TRIPS, and the WTO system is hence addressing these features in ongoing 
discussions.
96
 It follows that if origin disclosure were to be required in patent applications, this 





Marine microorganisms cannot be excluded from patenting and are hence patentable under 
TRIPS.
98
 However, discoveries, as opposed to inventions, do not generally qualify for patents. 
It is not easy to isolate discoveries of new biological material from e.g. microorganisms that 
are eligible for patenting. The rapid development of biotechnology has given rise to many 
complex legal questions during the past decades. What qualifies as an invention has evolved 
through changed practices so that bacteria, viruses and genes isolated from nature now can be 
patented.
99
 In several states discoveries of substances that already existed in nature are being 
patented.
100
 Ongoing complaints of patent decisions in the EU and the U.S. shows that there 
are still legal gray areas encompassing the patenting of genetic material.
101
 According to 
Article 27 of the TRIPS Agreement, patents have to be available for any inventions, whether 
products or processes, in all fields of technology, which includes biotechnology. The invention 
concept does not have a consolidated definition internationally, but it has to at least be a novel 
product or process without prior presence. American courts have defined some very specific 
exclusions to patentability; such as laws and phenomena of nature and naturally occurring 
substances.
102
 On the contrary, if an inventor alters something found in nature, it may be 
eligible for a patent. A genetically modified organism is defined as any living organism, e.g. 
plant, animal or bacteria that have had their genetic material altered by engineering. In the 
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U.S. Supreme Court Case, Diamond v. Chakrabarty, the latter had engineered a bacterium that 
broke down crude oil components.
103
 Since no such bacterium existed in nature, the Court 
concluded that this was a product of human ingenuity and could be patented.
104
 Still, materials 
isolated from naturally occurring substances are being patented without meaningful changes. 
Technically, there is no difference between the patenting of genes from microorganisms, 
plants or animals, but if you patent a gene and use it for plant breeding, plants you grow from 
that process may be effectively covered by the patent.  
 
There are clear restrictions on patenting plants and animals; through the TRIPS Agreement 
discretion is left with the members to exclude patentability of plants and animals other than 
microorganisms.
105
 Generally, members shall thus grant patent protection for microorganisms 
and for microbiological processes and non-biological, in contrast, patents on plant varieties or 
animal breeds are normally not provided, but if the inventions are not limited to specific plant 
varieties and animal species, it may be a feasible patent case. It is for example possible to 
patent a host cell of a plant which may be used to compose a medicine. Large corporations 
tend to file many patents to protect their investments, but if these patents lead to a market 
concentration and a decrease in biodiversity, such a development can be problematic, 
especially where it jeopardizes the livelihood of developing communities. From a democratic 
perspective, it is hence troubling that the European patent system is perceived as very closed, 
technocratic and limited largely to pure patent law. The enforcement of laws and treatment of 
complaints are conducted by people working in the patent field. Therefore, the patent logic is 
prevailing, and there is no Supreme Court with judges with non-patent background one can 
appeal the case to. Since this discussion is beyond the objective of this paper, a more in-depth 
analysis has to be left for another study. 
 
2.5.4 Appropriation in Areas Beyond National Jurisdiction 
Marine scientific research must not provide the legal foundation for any claims to the marine 
environment or its resources, in accordance with the LOSC Article 241. The reservation 
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regarding appropriation reaffirms similar provisions on the high seas and the Area.
106
 
However, there is an exception to the prohibition on appropriation of biological material in 
this region. Pursuant the LOSC Part XI, states have the right to conduct marine scientific 
research in the Area, which includes the right to collect genetic samples.
107
 The LOSC regime 
established under Part XIII is not restricted to any resource, in contrast to Part XI which 
specifically addresses the seabed mineral resources. The language is in general broadly 
phrased. The phrasing of Article 241, emphasizing “any claim” suggests broad coverage 
addressing public and private claims. Likewise, the reference to the “marine environment” 
lacks limits on its extent in the hydrosphere, so the seabed ought to be included in its scope. 
Further, Article 241 incorporates marine scientific research in areas beyond national 
jurisdiction as it refers to all parts of the ocean and is placed under the general provisions of 
the LOSC Part XIII. It is also natural to interpret “resources” as encompassing equally living 
and nonliving material. 
 
The genetic resources of the seabed in areas beyond national jurisdiction can also constitute a 
part of the marine environment. Article 241 covers marine scientific research on the deep 
seabed because “resources” in the Area is limited to mineral resources. In addition, high seas 
biological material should also be defined as part of the marine environment. The LOSC 
provisions stipulates that marine scientific research activities shall not provide the legal basis 
for a claim, but the patent claim does not necessarily have to be based on marine scientific 
research. It is possible to assert that the appropriation is not acquired directly through to the 
marine scientific activities, but instead a consequence of ingenuity in the terrestrial domain. 
However, marine scientific activities are vital for the subsequent exercises, and such a 
segregation of process components thus seems unproductive. One could in relation consider 
patent claims through marine scientific research legitimate, due to the close connection 
between marine scientific research and later ventures, but that would likely undermine the 
general nature of the commons. Nonetheless, contradicting interpretations of Article 241 is 
possible. In order to facilitate a better understanding, other sources such as preparatory works 
and routines should be given consideration. Reports expose that the clause was included to 
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prevent research from supporting claims of “exploitation rights or any other rights in areas 
beyond national jurisdiction.”
108
 As a result, patents awarded by virtue of marine genetic 
resources would conflict with Article 241. The first gene patents were issued in the 1970s, 
hence contemporary biotechnology was not among the prevailing issues during the LOSC 
negotiations.
109
 The negotiations signalized that a broad interpretation of “claim” was indeed 
intended. The current regime ironically insinuates that appropriation of genetic resources for 
scientific purposes is prohibited, while commercially oriented material sampling and patenting 
is accepted.
110
 This accordingly makes academic entrepreneurship, joint ventures and private 
funding of public institutions difficult to address effectively. External financing is in many 
cases vital due to the high costs associated with bioprospecting operations on the high seas and 
later in laboratories. If bioprospecting constitutes a part of the current or an extended marine 
scientific research regime, it may restrain states and their associated entrepreneurs from 
pursuing and awarding patents related to high sea genetic resources. The LOSC Article 244 
reinforces the divide between marine scientific research and bioprospecting, as the former 
must be published and disseminated while the results of the latter may obtain confidentiality. 
Bioprospectors and other entrepreneurial scientists ought to be rewarded for their financial 
risk. Nevertheless, further exploration of biological material in areas beyond national 
jurisdiction should not be discouraged by an ambiguous regime. Competition between 
different scientific disciplines, patents, publishing and market interests are among the features 
that are not adequately addressed under Part XIII.
111
 Perhaps bioprospecting may be better 
governed under a novel regime? 
 
2.5.5 Environmental obligations 
An overarching legal framework for marine environmental protection is embedded in the 
LOSC. Both Part VII and Part XII carry the environmental legislation addressing biological 
material in the high seas. Part XII outlines provisions for the protection and preservation of 
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marine ecosystems. These provisions are fairly broad and applicable to industries on a global 
scale. Article 192 stipulates the general duty to preserve and protect the marine environment. 
This principle covers all maritime zones. There is also an obligation to consistently with the 
LOSC avert and curtail marine pollution.
112
 In this setting, marine pollution means introducing 
energy or substances into the marine environment, which may harm the living resources of the 
ocean.
113
 Some of the biggest environmental threats to marine genetic resources in the high 
seas stem from fisheries, acidification and mining. However, bioprospecting is relatively 
moderate in scale and impact, and are thus rather more compatible with the effects derived 
from marine scientific research. The environmental concern is thus related to energy exuding 
activities causing subtle noise, light and temperature changes in the water, which is covered by 
the general provisions of Articles 194 to 196.
114
 Due to the lack of sufficient scientific 
information about the features and functions of high seas ecosystems, a case-based 
precautionary approach should be employed to safeguard against irreversible biodiversity loss. 
Articles 117 to 119 address high seas living resources in general, while Section 2 of Part VII is 
especially designed for fish stock conservation. Preventing environmental threats can be done 
unilaterally or in cooperation, in conformity with Articles 117 or 192. Article 118 stipulates 
the obligation to collaborate in order to underpin high seas management and conservation. The 
International Tribunal for the Law of the Sea (ITLOS) further confirmed that “the duty to 
cooperate is a fundamental principle in the prevention of pollution of the marine environment 
under Part XII of the Convention and general international law.”
115
 Article 117 obligates states 
to take measures “as may be necessary for the conservation of living resources”. An 
evolutionary interpretation is allowed for in the phrase “may be necessary”, granting novel 
approaches inclusion over time. More details are not provided by the LOSC to aid 
understanding in this regard.  
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The future ecosystem impact from bioprospecting is predicted to be low due to the small 
amount of biological resources that needs to be sampled.
116
 Because the bioprospectors 
benefits from preservation of biodiversity, there is a strong interdependence between the 
two.
117
 Even though there is uncertainty connected with these operations, the estimated impact 
is still fairly small and bioprospecting does thus not prompt extensive environmental measures 
as there is no evidence or prospects for serious or adverse effects being caused by these 
activities. Specific measures under Article 117 are neither prescribed generally, but have to be 
assessed on a case-to-case basis depending on the geographical context of the cruise. An in-
depth discussion of environmental issues is beyond the scope of this thesis, so the attention 
will be shifted to regulation relevant for resources of the seabed. The legality of the areas in 
the intersection between the high seas and the seabed will accordingly be subject to review. 
 
Even though bioprospecting is covered by limiting standards, it can licitly be conducted in 
areas beyond national jurisdiction. In the first section covering bioprospecting, duties of the 
LOSC differ with the legislative fundament. In the examination in a resource context, 
bioprospectors may freely utilize high seas genetic resources. There is no decisive 
interpretation providing that marine scientific research or other legislative concepts provide 
the basis for bioprospecting, but international agreements covering patents may not be 
compatible with certain parts of the LOSC. In order to facilitate a de lege ferenda analysis on 
access and benefit-sharing in areas beyond national jurisdiction, the existing benefit-sharing 
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Chapter 3 - Access and Equitable Sharing of Benefits 
 
3.1 The Concept 
 
Access and benefit-sharing for genetic resources from areas outside national jurisdiction is not 
explicitly referenced in LOSC. The benefit-sharing provisions found in Part XI, Articles 137 
(2) and 140 (1), explains that exploration and exploitation of the Area’s resources shall benefit 
mankind, while Articles 137 (2) and 140 (2) ensures that financial resources and other 
economic benefits will be shared equitably by the International Seabed Authority (ISA). 
Further, Article 144 (1) promotes and encourages technology transfer in order for all states to 
benefit. These provisions do, however, not cover genetic resources because Article 133 limits 
the scope to mineral resources at or beneath the seabed. This thus excludes resources in the 
adjacent water column. 
 
Under the high seas regime, the LOSC Part VII, there is no regime for genetic resources nor is 
there an absolute freedom to exploit these resources. Subject to Article 118, there is an 
obligation to cooperate in management of living material. Arrangements addressing access and 
benefit-sharing can contribute to strengthening the collaborative aspects. Furthermore, benefit-
sharing is treated in LOSC Part XIII in relation to marine scientific research, its Article 244 
(1) handles information from research, Article 244 (2) prescribes transfer of knowledge and 
data, and Article 242 again encourages international cooperation in research. In the Area, 
benefit-sharing linked to scientific research is covered in Article 143 (1) and (3), where 
scientific research should benefit mankind and research results disseminated to promote 
collaboration in international research. 
 
The challenge is to unify how states address the lack of direct references to vital concepts, and 
to guide stakeholders to adhere accordingly. In contrast to LOSC, access and benefit-sharing is 
listed in the CBD as a prioritized objective and subsequently echoed in other contexts of 
international law.
118
 ABS is not thoroughly defined, but access will in this setting be defined 
as an opportunity to physically claim biological resources, as well as the right to use and 
benefit from them. Benefitting from resources means gaining an advantage, while the act of 
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benefit–sharing transmits this advantage. Benefits can embody different structures; they can be 
concrete or intangible as well as financial or non-monetary. There are several examples of 
benefits found in Bonn guidelines.
119
 Examples of enlisted monetary benefits are inter alia 
access fees, co-ownership of IPR, joint ventures, and research funding, while the non-
monetary benefits consists of capacity building, research collaboration, distribution of 
scientific results and in other ways contributions to the local economy.
120
 The benefit 
catalogue is clearly diversified, and can even vary more extensively as these lists are not 
exhaustive. Potential benefit-sharing methods under the LOSC, including alternative ABS 




3.2 The Convention on Biological Diversity 
 
International instruments that potentially may contribute to a more holistic regime covering 
high seas bioprospecting, genetic resources and access and benefit-sharing shall be outlined in 
this section. This overview will subsequently serve as the fundament for further analysis of 
suitable regulative options promoting a more equitable ocean governance regime in areas 
outside national jurisdiction. 
 
Both the LOSC and the CBD have a significant number of contractors; practically all LOSC 
parties are also CBD parties. Its connection with the LOSC is governed by Article 22, which 
stipulates that the CBD shall be implemented “consistently with the rights and obligations of 
States under the law of the sea.” The CBD Article 22 thus reinforces the terms of the LOSC 
Article 311 (3), and if conflict were to arise the LOSC would normally prevail as other 
agreements shall not be “incompatible with the effective execution of the object and purpose 
of this Convention, and provided further that such agreements shall not affect the application 




                                               
119
 COP 6 Decision VI/24. 
120
 COP 6, Decision VI/24: Bonn Guidelines on access and benefit-sharing as related to genetic resources and fair and equitable sharing of 
the benefits arising out of their utilization, Appendix II (1) and (2) available at <http://www.cbd.int/decision/cop/default.shtml?id=7198> 
accessed 30 May 2013. 
121
 LOSC, art. 311 (3). 
36 
 
The CBD was established to provide a comprehensive framework for the conservation and 
sustainable use of biological diversity. It is unique in terms of being the only international 
instrument to address biological diversity. Areas both within and beyond national jurisdiction 
is addressed in the CBD, but not in the same manner.
122
 The current scope of the CBD is, in 
accordance with Article 4 (a), restricted to components “within the limits of its national 
jurisdiction.”
123
 Article 4 (b) continues to stipulate that the CBD governs activities and 
processes “regardless of where their effects occur, carried out under jurisdiction or control, 
within the area of its national jurisdiction or beyond the limits of national jurisdiction.”
124
 
Accordingly, where activities such as marine scientific research and bioprospecting are 
undertaken in the Area or the high seas and are subject to a CBD party’s jurisdiction, they may 
be covered by the CBD. Article 4 (a) rather than the subsequent Article 4 (b) perceived to have 
a stronger relation with the concept of “genetic resources.” Thus, biological resources in areas 
beyond national jurisdiction are essentially not regulated within the CBD. Parties are further 





 The CBD acknowledges “the sovereign rights of States over their natural resources, the 
authority to determine access to genetic resources rests with the national governments and is 
subject to national legislation.”
126
 Hence, the authority to determine access to genetic 
resources rests with the national governments and is accordingly also subject to their national 
regulations. On the other hand, access to genetic resources is left unregulated. 
 
One of the three CBD objectives is the “fair and equitable sharing of the benefits arising out of 
the utilization of genetic resources”.
127
 This mission is further detailed in several CBD 
provisions, but can also be traced back to the LOSC, and found in the voluntary Bonn 
Guidelines and the legally binding Nagoya Protocol.
128
 The framework promoting equitable 
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bioprospecting on the high seas can thus find legislative support in the CBD. It is expected 
that the contracting parties “create conditions to facilitate access to genetic resources for 
environmentally sound uses by other Contracting Parties and not to impose restrictions that 
run counter to the objectives of this Convention.”
129
 If access is granted, it “shall be on 
mutually agreed terms” and made “subject to prior informed consent of the Contracting Party 
providing such resources, unless otherwise determined by that party,” according to Article 
15.
130
 The Nagoya Protocol is particularly relevant with regard to access and benefit-sharing, 
and will henceforth be investigated. 
 
3.2.1 The Nagoya Protocol 
  
Because access and benefit-sharing provisions were considered too broad, countries did not 
successfully conform to the principles. The general framework on access and benefit-sharing 
in the CBD is complemented by the Nagoya Protocol. The latter is expected to enter into force 
by 2015 and is intended to enhance legal clarity.
131
 The third objective of the CBD is 
duplicated verbatim in the Nagoya Protocol’s objective, and further details the intention by 
including that access and benefit-sharing should reinforce “the conservation of biological 
diversity and the sustainable use of its components.”
132
 The Nagoya Protocol accordingly 
further consolidates the objectives of the CBD with the ABS concept. To facilitate access to 




In Article 10 of the Nagoya Protocol, parties must “consider the need for and modalities of a 
global multilateral benefit sharing mechanism to address the fair and equitable sharing of 
benefits derived from the utilization of genetic resources and traditional knowledge associated 
with genetic resources that occur in transboundary situations or for which it is not possible to 
grant or obtain prior informed consent.”
134
 A more effective approach to biological benefit-
sharing in the high seas could hence be materialized through such a system. Therefore it is 
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essential to further assert if bioprospecting on the high seas comprise exploitation where there 





3.3 The FAO Treaty 
 
The FAO Treaty was the first binding legislative body to operationalize the CBD concept of 
access and benefit-sharing, but the preceding treaty negotiations had progressed slowly 
because of a divide between the G77 block and the OECD nations.
136
 During the lawmaking 
process, the FAO Treaty was suggested to perhaps evolve into a CBD Protocol, but this idea 
was subsequently dismissed because it was perceived as more of an instrument of agriculture 
rather than an environmental compromise.
137
 The main focus in this section will thus be 
biological resources utilized directly or indirectly for food, in contrast to the CBD where 
access and benefit-sharing is addressed regardless of intent and sector.  
 
A system of facilitated access to a shared resource pool is included in Part IV, Article 12, of 
the FAO Treaty. For the purpose of conservation and use, access is only given to “research, 
breeding and training for food and agriculture, provided that such purpose does not include 
chemical, pharmaceutical and/or other non-food/feed industrial uses.”
138
 As the results of 
bioprospecting targets a broader market, the limited scope of the FAO Treaty does not provide 
sufficient coverage. Some of the system traits could be beneficial in respect of areas beyond 
national jurisdiction. For example, parties could be provided access to something that they not 
normally would be able to access. Article 12 (4) of the FAO Treaty provides that facilitated 
access under the multilateral system must be subject to a standard material transfer agreement 
(MTA).
139
 Signing of a MTA is the only requirement for accessing biological resources under 
the multilateral system.
140
 This agreement specifies that the information about all transfers is 
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to be supplied the FAO secretariat by the provider. Under the MTA, recipients shall not claim 
intellectual property rights that restrict access to the resources provided.
141
 Further, the 
multilateral system should be provided all relevant research results which are non-
confidential.
142
 The recipient is also obligated to pay a fixed percentage of sales of a 




One of the features contributing to caution among recipients of the MTA, is the fact that there 
is no limitation on time with regards to the obligation to share benefits. Thus, an endpoint for 
sharing of benefits could be stipulated, in order not to hamper innovation as well as to provide 
more stable frames for investors.
144
 However, relative to a monetary obligation earlier in the 
product life cycle, an endpoint does not necessarily affect the incentive to invent, because an 
obligation as late as 20 years into the future would be an issue of minor salience in comparison 
to a more immediate monetary contribution.
145
 Since a scientific process may take years to 
finish, it can correspondingly take multiple years for financial benefits may be accumulated, 
making early monetary contributions less favorable. Hence, this notion could be supported by 
the fact that no compulsory payments have thus far been materialized under the auspices of the 
FAO Treaty.
146
 A discrepancy may be made between legislative enforcement and softer 
approaches enforcement by raising awareness, considering the feasibility of enforcement of 
the access and benefit-sharing elements in the FAO Treaty. 
 
Article 13 of the FAO Treaty details how benefits ought to be shared. The mandatory 
monetary benefit-sharing clauses is stipulated in Article 13 (2) (d) and refers to 
commercialized products, based on biological resources acquired from the multilateral system. 
Such payments are excluded where there are no restrictions on research and breeding. In the 
latter case, financial contributions from the developer of a commercialized product are only 
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encouraged and not compulsory. Article 13 also prescribes non-monetary benefits, which 
includes transfer of technology, building capacity and distributing information. Measures to 
ensure compliance were detailed by a designated Compliance Committee. Absence of 
compliance may be remedied by Contracting Parties, whether it involves activities under their 
control or where other parties fail to comply.   
 
The ex situ resources are more accessible and better assessed in comparison to the less 
scrutinized in situ material. Thus, multilateral system covers the former category more 
effectively. The consequence of the main emphasis being on ex situ resources is that the scope 
of the FAO Treaty fails to address bioprospecting in pristine areas beyond national 
jurisdiction. The treaty also supports fair and equitable sharing of benefits, sustainable use and 
conservation of plant genetic resources for food and agriculture, in conformity with the CBD. 
The two conventions regard access and benefit-sharing differently.  
 
Even though the FAO Treaty has a significant amount of parties, it is vulnerable to 
fragmentation in the implementation process. System cohesion is thus necessary. The 
effectiveness of the system is also contingent on the amount of material governed by the 
multilateral system, as the availability and benefit-sharing has a better chance of making a 




The FAO Treaty contains elements which can inspire change in the current regime for 
biological material. Together with its multilateral system, the FAO Treaty displays favorable 
mechanisms, such as the multilateral system of access and benefit-sharing, and may hence 
serve as a model for future instruments. Since the access process is balanced against the 
benefit-sharing prospect, the success of the system is contingent on the performance and 
operationalization of both components. Thus, the extent of the benefit-sharing depends on the 
benefits yielded, but determining the specific point in which a product will trigger benefit-
sharing can be challenging. 
 
 





3.4 Regulative Options 
Arico, Salpin and Drankier et al. are among the scholars who have examined the feasible 
alternatives for governing genetic resources in areas beyond national jurisdiction. Their 
research will henceforth be drawn upon.  
 
The first apparent alternative is to maintain the current system, where access and benefit-
sharing regarding marine biological material is unregulated. Because relevant international 
regulations stipulate that a counterpart is necessary when drafting contracts, genetic resources 
in areas beyond national jurisdiction cannot be accessed through to contractual agreements. 
The vessels bioprospecting on the high seas thus have an obligation to adhere to the “exclusive 
jurisdiction on the high seas flag states”
148
 The flag states are hence the principal enforcer of 
measures and standards concerning activities conducted on the high seas and in the Area. 
When the minimum requirements of the LOSC are met, states are free to regulate the 
conditions of access to biological material for their nationals. Tvedt and Jørem suggest that an 
option in this regard is to make nationals subject to permits that could obligate benefit-
sharing.
149
 Another alternative is a scenario where the UNGA adopts guidelines highlighting 
coordination of flag state relationships.
150
 These guidelines can be specified further by a code 
of conduct, as guidelines comparatively are not rich in detail.
151
 The non-legally binding 
nature may be a temporary arrangement which may evolve into something more permanent. In 
general, states would rather avoid placing economic burdens on national industries as this 
would give them a relative disadvantage in the international market.
152
 An international 
approach is hence preferred. 
 
Further, the CBD framework may be applied to activities and processes under state control or 
jurisdiction. Regulations within this framework can also merely address activities that may 
have considerable repercussions for the environment. Thus, for the CBD to cover access and 
benefit-sharing in areas beyond national jurisdiction, an expanded mandate may be needed. An 
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In the Nagoya Protocol there is no particular reference to biological resources from marine 
areas beyond national jurisdiction. The intention of not making biological material from areas 
beyond national jurisdiction subject to a new access and benefit-sharing regime under the 
CBD is thus mirrored this decision.
154
 Regarding the alternative of applying a regime 
addressing marine genetic resources in the Area, the international community is split. This 
separation primarily concerns the question of whether the genetic resources of the seabed are 
covered by the common heritage of mankind concept. Relevant principles could thus be 
applied to genetic resources, if they were to be subject to the Area. Accordingly, resources 
should be utilized exclusively for peaceful purposes and neither commercial companies nor 
states can thus appropriate these resources. 
 
The prevalent bilateral structure regarding resource transactions in the access and benefit-
sharing system, where one state authorize access to a user in return for a portion of its benefits, 
is a prevalent shortcoming. Since other states with equivalent resources have to abstain from 
these benefits, these agreements can provoke rivalry and may as a consequence be inequitable, 
and regional and global funds have hence been initiated to remedy the effects of this 
practice.
155
 Nevertheless, the factual source states may stay unknown if the geographical 
distribution of the resource is not sufficiently mapped. Efficiency is impeded by the bilateral 
agreements as the state providing the resource, depend on the developer when supervising the 
resource use. Thus, resource surveillance is not feasible since resources may be spread 
between different users and applied in very different contexts. To prevent illicit use of 
resources, the current access and benefit-sharing system features bureaucratic processes.  
 
Biological databases containing an overview of genetic resources, their distribution and origin 
could hence cover a gap in the existing system and strengthen transboundary cooperation.
156
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Through centralized databases, a product could be traced to all the states where the genetic 
ingredient is located, and hence enact the Nagoya Protocol’s global multilateral benefit-
sharing system. This could constitute a more equitable approach, because benefits would be 
distributed to all the identified source states. Furthermore, valuable information about 
companies, intellectual property rights and scientific papers connected with use of the 
resources would be provided by these databases. A summary of all relevant data on uses of 
genetic resources since it was accessed would thus be provided by such a system. The provider 
states could use the database to request benefit sharing when a product is commercialized. In 
general, since individual bureaucracy can be cut and regulations relaxed, research and 
development can be better promoted. These databases would strengthen the objective of the 
CBD and support the multilateral mechanism initiated under the Nagoya Protocol. The vitality 
of these databases should thus be recognized by all parties in order to enhance the current 
access and benefit-sharing system. 
 
Furthermore, an international agreement is needed to facilitate access to biological resources 
on the seabed for those interested in commercial development. From such an alternative it 
follows that benefits accumulated from these activities should be shared with mankind. 
Nonetheless, the current regime exclusively concern mineral resources. For the Area and the 
ISA’s regulative scope to be extended to cover genetic resources, it could be done by a LOSC 
amendment, establishing an implementing agreement, adopting a Protocol, or ratifying an 
agreed interpretation of the LOSC, while stipulating that the genetic resources on the deep 
seabed are subject either to the freedom of the highs seas or the Area.
157
 Either way, an 
extensive reform would be necessary to extend the ISA’s mandate and the relation between 
bioprospecting and marine scientific research need to be resolved.
158
 A novel LOSC 
implementing agreement addressing living resources in areas beyond national jurisdiction and 
matters related to access and benefit-sharing, may consequently also resume the LOSC 
negotiations, and with many stakeholders involved, the process may tie up considerable 
resources. Judging by the current division of interests it is not unreasonable to expect a 
stalemate when scrutinizing the application of freedom of the high seas or the common 
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heritage of mankind. An implementation agreement comparable to the arrangements 
established in relation to Part XI and the Fish Stocks Agreement would benefit from 
optimization regarding areas beyond national jurisdiction.
159
 Still, an implementation 
agreement establishing a multilateral system for living resources in areas beyond national 
jurisdiction does not seem viable in the current political climate.
160
 Other regulatory regimes 
shall thus be examined. Within the LOSC framework, the CBD and the Area’s common 
heritage regime will be further investigated. 
 
3.5 An International Agreement Under Siege? 
 
A mechanism allocating access to genetic resources in areas beyond national jurisdiction is 
necessary if a permissive complex is preferred. The COP of the CBD is held every two years 
and is thus perhaps not the best body for operational administration of more frequent access 
inquiries.
161
 A more compact and enduring mechanism, for example an subordinate body, 
would be preferred in relation to access and benefit-sharing, in order to more readily manage 




In a regime applying the common heritage of mankind, the deep ocean floor and its biological 
material would not be subject to appropriation. Benefits resulting from exploitation should be 
shared with mankind and these tasks would thus entail institutional administration.
163
 For 
example, delegating a managing mandate to the ISA could facilitate increased competence and 
systemic coherence. Because of the unique mix of resources on the deep seabed, a revised 
regime devoted to genetic resources in areas beyond national jurisdiction may not be entirely 
compatible with the current regulative format of the Area. On the other hand, stakeholders 
benefiting from genetic resources being subject to the freedom of the high seas are not eager to 
renegotiate the existing system. This includes states with industries heavily invested in biotech 
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and marine genetic patents. These stakeholders are concerned that an increased emphasis on 
the common heritage concept will lead to a bureaucratic system that impedes private initiative 
and innovation. The contemporary infrastructure of the ISA may not be ideal to balance 
diverging interests related to genetic resources, as its institutional composition revolves around 
minerals and the mining sector. Because of its mineral resource focus, the distinct interests of 
investors, consumer and producer states in relation to deep seabed mining are emulated in 
ISA’s Council. There are additionally no capacities of significance devoted to bioprospecting 
and intellectual property rights nor benefit-sharing in this structure. Its sector specific anatomy 
thus makes it less suited for biotech endeavors. 
 
With sufficient backing, there may also be room for a more extensive compromise with 
enhanced environmental measures in areas beyond national jurisdiction. A coalition of 
developing and developed nations has proposed that UN should start negotiating an 
international agreement to improve high seas governance. In addition to addressing how the 
benefits from commercial operations should be shared, the proposal also stipulates protected 
areas and impact evaluations regarding proposed activities outside national jurisdiction. If a 
compromise on the common heritage of mankind is not feasible, there is a need for alternative 
solutions.  
If there is agreement on the common heritage of mankind, a protocol based on the CBD 
appears to be the best solution. Both the CBD’s scope and objectives would be complemented 
by addressing biological material in areas beyond national jurisdiction. However, at the 
moment there is not much unity in relation to the expansion of the common heritage regime. 
Drankier et al projects that the most likely outcome is no consensus on the application of the 
common heritage concept, and that it hence is vital to replicate the Antarctic Treaty’s 
‘agreement to disagree’ as a fundament for further negotiations.
164
 In accordance with that 
sentiment, the exponents of a revised regime in areas beyond national jurisdiction should 
further evaluate sustainable solutions for a multilateral benefit-sharing regime. Clearly 
prioritizing to strengthen the legal structures related to access to both in situ and ex situ 
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resources and focusing on sharing non-monetary benefits may be an initial way forward. Their 



































Chapter 4 - Conclusions 
 
Technological evolution has facilitated increased commercial exploration of biota located in 
increasingly extreme spheres over the last decades. Like most commons, the areas beyond 
national jurisdiction are inadequately regulated. Patents based on genetic resources of the high 
seas document that bioprospecting has been conducted in these areas for some time now, still 
sufficient regulations are absent. Bioprospecting in areas beyond national jurisdiction involves 
high risks for stakeholders, not only due to the hostile location of these resources but also 
because of substantial uncertainty connected with clinical trials that over time accumulate high 
costs. Major investments are thus required. Regardless of these obstacles, successful products 
may generate significant return on investment and considering the abundance of unidentified 
marine microorganisms in pristine habitats, it is likely that industrial and scientific interest will 
persist. Nevertheless, new regulations must thus not hamper incentives to invest in these costly 
ventures, yet at the same time conservation efforts should be promoted through remedial 
mechanisms. The fair and equitable sharing of benefit can support these mechanisms, by 
sharing vital scientific findings. 
 
The point of departure in this study, was thus to find which existing standards could be 
applicable to bioprospecting, and to subsequently address how to remedy legislative 
inconsistencies. Accordingly, mechanisms which can contribute to distributing the benefits 
derived from bioprospecting in a fair and equitable manner were investigated and viable 
regulative options highlighted. 
 
In order to examine which existing standards might be applicable to bioprospecting and 
genetic resources in areas beyond national jurisdiction, the LOSC provisions of Part VII and 
Part XI on the high seas and the Area were scrutinized. Resources governed by the LOSC Part 
XI are explicitly defined as “mineral resources”. Hence, genetic resources are currently not 
subject to this regime. The high seas are in customary and conventional sources considered res 
communis, and accordingly the resources in this sphere are open to all; neither state nor 
organization can control the allocation of these resources. Some developed nations with vested 
interests in biotechnological industries supports the principles of open access and “first-come, 
first-serve” in the LOSC Part VII, in contrast to other major groups defending the stance that 
48 
 
this conflicts with the very logic of international law. Of the activities explicitly recorded as 
subject to the high seas freedoms, “marine scientific research” was found to be most 
compatible, as both concepts share traits such as similar research methods regarding data 
collection, sampling and laboratory work. There is currently no internationally agreed 
definition of “marine scientific research” or “bioprospecting.” However, clarifying these 
concepts and their compatibility has proved vital for establishing the rights and obligations 
that cover bioprospecting. Protecting innovations based on marine genetic resources conflicts 
with the LOSC duty of dissemination and publication of scientific results and this thus needs 
special attention in a novel regulative structure. Another significant difference is the objective 
of profit for commercial bioprospectors. 
 
Previously, utilization was an ambiguous term, as it did not involve restraints of significance. 
With the CBD complex, particularly the Nagoya Protocol, that changed. Because it prompts 
benefit-sharing, the CBD objective “utilization of genetic resources” is a core concept relating 
to biological material. Even though the Nagoya Protocol was an innovation with regard to 
access and benefit-sharing, the vague references to research and development does not 
stipulate very accurately what “utilization” constitutes. Other sources interpreting 
“biotechnology” and “utilization” should thus be considered where the Nagoya Protocol fails 
to provide additional instructions.
165
 These systems specify uses which are projected into 
activities reconstructing biological structures examine molecules and administrate biological 
data. In areas beyond national jurisdiction, there is no existing international authority to 
address bioprospecting. The Nagoya Protocol was established within the CBD framework to 
equitably distribute the benefits derived from genetic resources, but it did not address the legal 
lacuna concerning genetic resources in areas outside national jurisdiction. Hence, the legal 
status of the genetic resource is currently dependent on bilateral relations and state regulations, 
which can hamper conservation efforts as well as effective access and benefit-sharing.  
 
Requirement prescribing disclosure of origin is among the efforts made by individual states. 
For a more coherent and effective approach to access and benefit-sharing in the international 
                                               




community, enhanced measures are necessary. To comply with international agreements, user 
parties could implement conforming measures and ought to equally allow provider states to 
invoke force regarding relevant access and benefit-sharing provisions. 
 
Finally, a regime dedicated to genetic resources in areas beyond national jurisdiction can be 
materialized if there is sufficient political enthusiasm and consensus concerning the 
appropriate instruments. Provided that there is enough political support, an access and benefit-
sharing system could be sustainable, but there is hitherto a need to find the most appropriate 
legislative vehicle. Further research on mechanisms that may align diverging interests are 
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